Analyst Recommendations

Ascendiant analyst issues BUY recommendation for SURG on April 1, 2024 03:06AM ET. The previous analyst recommendation was Buy.SURG was trading at $3.85 at issue of the analyst...

April 1, 2024   SURG 2.86%

Cantor Fitzgerald analyst issues OVERWEIGHT recommendation for ORLY on April 1, 2024 01:14AM ET. The previous analyst recommendation was Overweight.ORLY was trading at $1128.88 at issue of the...

April 1, 2024   ORLY 2.40%

Wells Fargo analyst issues OVERWEIGHT recommendation for ORLY on April 1, 2024 01:14AM ET. The previous analyst recommendation was Overweight.ORLY was trading at $1128.88 at issue of the...

April 1, 2024   ORLY 2.40%

Citigroup analyst issues BUY recommendation for HD on March 31, 2024 10:57AM ET. The previous analyst recommendation was Buy.HD was trading at $383.6 at issue of the analyst...

April 1, 2024   HD 4.74%

Jefferies analyst issues BUY recommendation for MSFT on March 31, 2024 09:08PM ET. The previous analyst recommendation was Buy.MSFT was trading at $420.72 at issue of the analyst...

April 1, 2024   MSFT 0.63%

UBS analyst issues BUY recommendation for PVH on March 31, 2024 11:10AM ET. The previous analyst recommendation was Buy.PVH was trading at $140.61 at issue of the analyst...

April 1, 2024   PVH 5.61%

Daiwa analyst issues OUTPERFORM recommendation for NXT on March 29, 2024 09:05AM ET. NXT was trading at $56.27 at issue of the analyst recommendation.The overall analyst consensus :...

March 29, 2024   NXT 3.68%

Stifel Nicolaus analyst issues SECTOR PERFORM recommendation for DVN on March 28, 2024 03:00PM ET. The previous analyst recommendation was Sector Perform.DVN was trading at $50.215 at issue...

March 28, 2024   DVN -0.24%

RBC Capital analyst issues SECTOR PERFORM recommendation for BB on March 28, 2024 03:26PM ET. The previous analyst recommendation was Sector Perform.BB was trading at $2.76 at issue...

March 28, 2024   BB -3.61%

Rosenblatt Securities analyst issues UNDERPERFORM recommendation for CXM on March 28, 2024 04:00PM ET. The previous analyst recommendation was Underperform.CXM was trading at $12.27 at issue of the...

March 28, 2024   CXM 2.54%